Skip to content

ARDX

Ardelyx, Inc.

NASDAQ · USHealthcareBiotechnology
$5.09-2.12%

Price as of Jul 20, 2026

ARDX capital

Ardelyx, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
1.40x
Net debt / equity
1.19x
Debt / assets
0.41x
Debt / EBITDA
-8.16x
Net debt / EBITDA
-6.94x

Liquidity & coverage

Current ratio
3.49x
Quick ratio
3.28x
Cash ratio
2.17x
Interest coverage
-1.29x
EBITDA / interest
-0.88x
Working capital
$272.3M

Cash & dividend

FCF / debt
-0.18x
Cash flow / debt
-0.17x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.